Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study
Emergency and Critical Care Medicine · 2022
DOI: 10.1097/ec9.0000000000000026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency and Critical Care Medicine, 2022. Verfasst von Xianlong Zhou und 22 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The coronavirus disease 2019 (COVID-19) has affected approximately 2 million individuals worldwide; however, data regarding fatal cases have been limited.
Objective
To report the clinical features of 162 fatal cases of COVID-19 from 5 hospitals in Wuhan between December 30, 2019 and March 12, 2020.
Methods
The demographic data, signs and symptoms, clinical course, comorbidities, laboratory findings, computed tomographic (CT) scans, treatments, and complications of the patients with fatal cases were retrieved from electronic medical records.
Results
The median patient age was 69.5 (interquartile range: 63.0–77.25) years, and 80% of the patients were over 61 years. A total of 112 (69.1%) patients were men. Hypertension (45.1%) was the most common comorbidity, while 59 (36.4%) patients had no comorbidity. At admission, 131 (81.9%) patients had severe or critical COVID-19, whereas 39 (18.1%) patients with hypertension or chronic lung disease had moderate COVID-19. In total, 126 (77.8%) patients received antiviral treatment, while 132(81.5%) patients received glucocorticoid treatment. A total of 116 (71.6%) patients were admitted to the intensive care unit (ICU), and 137 (85.1%) patients received mechanical ventilation. Most patients received mechanical ventilation before ICU admission. Approximately 93.2% of the patients developed respiratory failure or acute respiratory distress syndrome. There were no significant differences in the inhospital survival time among the hospitals ( P =0.14).
Conclusion
Young patients with moderate COVID-19 without comorbidity at admission could also develop fatal outcomes. The in-hospital survival time of the fatal cases was similar among the hospitals of different levels in Wuhan.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai'an, Shandong, China.
- Emergency Department, General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China.
- Intensive Care Unit, Huazhong University of Science and Technology Union Jiangbei Hospital, Wuhan, Hubei, China.
- Intensive Care Unit, Wuhan Third Hospital, Wuhan, Hubei, China.
- Department of Urology, General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China.
Zitieren
APA
Zhou, X., Ding, G., Fang, Q., Guo, J., Yang, L., Wang, P., Fu, S. Z., Li, A., Xia, J., Yu, J., Xia, J., Ma, M., Hu, Z., Huang, L., Liu, R., Jiang, C., Li, S., Yu, M., Xu, X., …, & Zhao, Z. (2022). Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study. Emergency and Critical Care Medicine. https://doi.org/10.1097/ec9.0000000000000026
Vancouver
Zhou X, Ding G, Fang Q, Guo J, Yang L, Wang P, et al. Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study. Emergency and Critical Care Medicine. 2022. doi:10.1097/ec9.0000000000000026
BibTeX
@article{Zhou2022,
author = {Zhou, Xianlong and Ding, Guoyong and Fang, Qing and Guo, Jun and Yang, Luyu and Wang, Ping and Fu, Shou-Zhi and Li, Ang and Xia, Jian and Yu, Jiangtao and Xia, Jianyou and Ma, Min and Hu, Zhuanzhuan and Huang, Lei and Liu, Ruining and Jiang, Cheng and Li, Shaoping and Yu, Mingxia and Xu, Xizhu and Zhao, Yan and Hu, Quan and Xing, Weijia and Zhao, Zhigang},
title = {Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study},
journal = {Emergency and Critical Care Medicine},
year = {2022},
doi = {10.1097/ec9.0000000000000026}
}
EUVIMED